This shift could drive the obesity market to exceed $100 billion annually, reducing overall healthcare costs by addressing comorbidities associated with obesity
The receptor is a class B G-protein-coupled receptor that signals mainly through cyclic AMP, and it is expressed far beyond the pancreas, in the brain, gut, vasculature, heart, and kidney
Patients felt better, and their cardiovascular risk profile improved a lot
Its effectiveness is promising, with the TRIUMPH-1 Phase 3 trial revealing that participants achieved up to a 28.3% reduction in body weight over 80 weeks
J., Weimer, T., Kronthaler, U., Lang, W
Keep it out of the light to prevent degradation